Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 172

1.

Characterization of Siglec-5 (CD170) expression and functional activity of anti-Siglec-5 antibodies on human phagocytes.

Erickson-Miller CL, Freeman SD, Hopson CB, D'Alessio KJ, Fischer EI, Kikly KK, Abrahamson JA, Holmes SD, King AG.

Exp Hematol. 2003 May;31(5):382-8.

PMID:
12763136
2.

Identification of the CD33-related Siglec receptor, Siglec-5 (CD170), as a useful marker in both normal myelopoiesis and acute myeloid leukaemias.

Virgo P, Denning-Kendall PA, Erickson-Miller CL, Singha S, Evely R, Hows JM, Freeman SD.

Br J Haematol. 2003 Nov;123(3):420-30.

PMID:
14617000
3.

Human-specific expression of Siglec-6 in the placenta.

Brinkman-Van der Linden EC, Hurtado-Ziola N, Hayakawa T, Wiggleton L, Benirschke K, Varki A, Varki N.

Glycobiology. 2007 Sep;17(9):922-31. Epub 2007 Jun 18.

PMID:
17580316
4.

The role of receptors for tumour necrosis factor-alpha in the induction of human polymorphonuclear neutrophil chemiluminescence.

Zeman K, Kantorski J, Paleolog EM, Feldmann M, Tch├│rzewski H.

Immunol Lett. 1996 Oct;53(1):45-50.

PMID:
8946217
5.

Different patterns of Siglec-9-mediated neutrophil death responses in septic shock.

von Gunten S, Jakob SM, Geering B, Takala J, Simon HU.

Shock. 2009 Oct;32(4):386-92. doi: 10.1097/SHK.0b013e3181a1bc98.

PMID:
19295491
6.

Characterization of siglec-5, a novel glycoprotein expressed on myeloid cells related to CD33.

Cornish AL, Freeman S, Forbes G, Ni J, Zhang M, Cepeda M, Gentz R, Augustus M, Carter KC, Crocker PR.

Blood. 1998 Sep 15;92(6):2123-32.

7.

Cross-linking of CD45 enhances activation of the respiratory burst in response to specific stimuli in human phagocytes.

Liles WC, Ledbetter JA, Waltersdorph AW, Klebanoff SJ.

J Immunol. 1995 Aug 15;155(4):2175-84.

PMID:
7636266
8.

Deletion polymorphism of SIGLEC14 and its functional implications.

Yamanaka M, Kato Y, Angata T, Narimatsu H.

Glycobiology. 2009 Aug;19(8):841-6. doi: 10.1093/glycob/cwp052. Epub 2009 Apr 15.

PMID:
19369701
9.

Characterization of the human neutrophil C1q receptor and functional effects of free ligand on activated neutrophils.

Eggleton P, Ghebrehiwet B, Coburn JP, Sastry KN, Zaner KS, Tauber AI.

Blood. 1994 Sep 1;84(5):1640-9.

10.

OB-BP1/Siglec-6. a leptin- and sialic acid-binding protein of the immunoglobulin superfamily.

Patel N, Brinkman-Van der Linden EC, Altmann SW, Gish K, Balasubramanian S, Timans JC, Peterson D, Bell MP, Bazan JF, Varki A, Kastelein RA.

J Biol Chem. 1999 Aug 6;274(32):22729-38. Erratum in: J Biol Chem 1999 Sep 24;274(39):28058.

13.

CD66a, CD66b, CD66c, and CD66d each independently stimulate neutrophils.

Skubitz KM, Campbell KD, Skubitz AP.

J Leukoc Biol. 1996 Jul;60(1):106-17.

PMID:
8699114
14.

Characterization of Siglec-H as a novel endocytic receptor expressed on murine plasmacytoid dendritic cell precursors.

Zhang J, Raper A, Sugita N, Hingorani R, Salio M, Palmowski MJ, Cerundolo V, Crocker PR.

Blood. 2006 May 1;107(9):3600-8. Epub 2006 Jan 5.

15.

Ganglioside GD3 expression on target cells can modulate NK cell cytotoxicity via siglec-7-dependent and -independent mechanisms.

Nicoll G, Avril T, Lock K, Furukawa K, Bovin N, Crocker PR.

Eur J Immunol. 2003 Jun;33(6):1642-8.

16.

Interactions of lipopolysaccharide with neutrophils in blood via CD14.

Weingarten R, Sklar LA, Mathison JC, Omidi S, Ainsworth T, Simon S, Ulevitch RJ, Tobias PS.

J Leukoc Biol. 1993 May;53(5):518-24.

PMID:
7684764
17.

Myeloid precursors and acute myeloid leukemia cells express multiple CD33-related Siglecs.

Nguyen DH, Ball ED, Varki A.

Exp Hematol. 2006 Jun;34(6):728-35.

PMID:
16728277
18.

Siglec-5 (CD170) can mediate inhibitory signaling in the absence of immunoreceptor tyrosine-based inhibitory motif phosphorylation.

Avril T, Freeman SD, Attrill H, Clarke RG, Crocker PR.

J Biol Chem. 2005 May 20;280(20):19843-51. Epub 2005 Mar 15.

19.

Supplemental Content

Support Center